What's the deal with Aduhelm?
Science unscripted - A podcast by DW.COM | Deutsche Welle
It's a 'breakthrough' drug for Alzheimer's… but no one's sure if it actually works. There are also clear risks of side effects... and yet it was approved by the top US drug agency (prompting three scientists to quit). What is going on?
